Purpose: The aim of the study was to evaluate the efficacy and toxicity of Etanidazole, a hypoxic cell sensitizer, combined with radiotherapy in the treatment of head and neck squamous cell carcinoma.
Methods And Materials: A total of 374 patients from 27 European centers were included in this trial between 1987 and 1990. Treatment was either conventional radiotherapy alone (between 66 Gy in 33 fractions and 74 Gy in 37 fractions, 5 fractions per week), or the same radiotherapy dose plus Etanidazole 2 g/m2, three times weekly for 17 doses. A minimization procedure, balancing for center, site, and T stage (T1-T3 vs. T4) was used for randomization.
Results: Among the 187 patients in the Etanidazole group, 82% received at least 14 doses of the drug. Compliance to the radiotherapy protocol was 92% in the Etanidazole group and 88% in the control group; the main cause of deviation was acute toxicity, which was observed at an equal rate in the two treatment groups. Fifty-two cases of Grade 1 to 3 peripheral neuropathy were observed in the Etanidazole group vs. 5 cases, all of Grade 1, in the control group (p < 0.001). The 2-year actuarial loco-regional control rates were 53% in the Etanidazole group and 53% in the control group (p = 0.93), and the overall 2-year survival rates were 54% in each group (p = 0.99).
Conclusion: Adding Etanidazole to conventional radiotherapy did not afford any benefit for patients with head and neck carcinoma. This study failed to confirm the hypothesis of a benefit for patients with N0-N1 disease, which had been suggested by the results of a previous study (10).
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/s0360-3016(97)00327-1 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Intra-articular etanercept attenuates pain and hypoxia from TMJ loading in the rat.
J Orthop Res
June 2020
Oral and Maxillofacial Surgery, School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.
Article Synopsis
- Mechanical overloading and biochemical changes like inflammation lead to cartilage degeneration and pain in the temporomandibular joint (TMJ) associated with osteoarthritis (OA), but the early effects on chondrocytes are unclear.
- A study in a rat TMJ pain model examined hypoxia-inducible factors (HIF)-1α/2α and hypoxia levels after different jaw loading conditions, revealing that higher loading magnitudes correlated with increased HIF-2α and hypoxia.
- Treatment with etanercept (a TNF inhibitor) reduced pain sensitivity and HIF-2α levels, suggesting that TMJ loading can drive changes in cartilage health that may be influenced by TNF.
In vivo drug screening method of radiosensitizers using tumor-bearing chick embryo.
Enzymes
November 2019
Central Research Resource Branch, Cancer Research Institute, Kanazawa University, Kanazawa, Japan.
In radiotherapy, tumor hypoxia is the main factor responsible for treatment resistance, and the development of radiosensitizers that can overcome this is imperative. However, many drugs that are effective in vitro and in vivo fail in clinical trials, and thus it is necessary to develop an animal model that can be used for the correct evaluation of pharmacokinetics and activity. Developing chicken eggs are commonly used in various research fields such as anticancer drug sensitivity tests and cardiotoxicity tests.
View Article and Find Full Text PDF18F-EF5 PET Is Predictive of Response to Fractionated Radiotherapy in Preclinical Tumor Models.
PLoS One
June 2016
Department of Radiation Oncology, Stanford University, Stanford, CA, United States of America.
We evaluated the relationship between pre-treatment positron emission tomography (PET) using the hypoxic tracer 18F-[2-(2-nitro-1-H-imidazol-1-yl)-N-(2,2,3,3,3- pentafluoropropyl) acetamide] (18F-EF5) and the response of preclinical tumor models to a range of fractionated radiotherapies. Subcutaneous HT29, A549 and RKO tumors grown in nude mice were imaged using 18F-EF5 positron emission tomography (PET) in order to characterize the extent and heterogeneity of hypoxia in these systems. Based on these results, 80 A549 tumors were subsequently grown and imaged using 18F-EF5 PET, and then treated with one, two, or four fraction radiation treatments to a total dose of 10-40 Gy.
View Article and Find Full Text PDFPrognostic value of tumour blood flow, [¹⁸F]EF5 and [¹⁸F]FDG PET/CT imaging in patients with head and neck cancer treated with radiochemotherapy.
Eur J Nucl Med Mol Imaging
November 2014
Turku PET Centre, Kiinamyllynkatu 4-8, 20521, Turku, Finland,
Purpose: In order to improve the treatment of squamous cell carcinoma of the head and neck, precise information on the treated tumour's biology is required and the prognostic importance of different biological parameters needs to be determined. The aim of our study was to determine the predictive value of pretreatment PET/CT imaging using [(18)F]FDG, a new hypoxia tracer [(18)F]EF5 and the perfusion tracer [(15)O]H₂O in patients with squamous cell cancer of the head and neck treated with radiochemotherapy.
Methods: The study group comprised 22 patients with confirmed squamous cell carcinoma of the head and neck who underwent a PET/CT scan using the above tracers before any treatment.
Novel nitroimidazole alkylsulfonamides as hypoxic cell radiosensitisers.
Bioorg Med Chem
April 2014
Auckland Cancer Society Research Centre, University of Auckland, Private Bag 92019, Auckland 1142, New Zealand. Electronic address:
A novel class of nitroimidazole alkylsulfonamides have been prepared and evaluated as hypoxia-selective cytotoxins and radiosensitisers. The sulfonamide side chain markedly influences the physicochemical properties of the analogues: lowering aqueous solubility and raising the electron affinity of the nitroimidazole group. The addition of hydroxyl or basic amine groups increased aqueous solubility, with charged amine groups contributing to increased electron affinity.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!